62 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
to align with our DEI goals each year. These goals include influencing our commitment to DEI through leadership and executive culture, fostering … of a percentage of such officer’s annual base salary, subject to achievement of corporate goals as determined by the compensation committee.
Mr. Chee’s
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
8 Jan 24
Regulation FD Disclosure
7:06am
quarter of 2025. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations
8-K
EX-99.1
SYRS
Syros Pharmaceuticals Inc.
6 Dec 23
Regulation FD Disclosure
7:05am
expenditure requirements into 2025. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results
8-K
b2k9hx 0yv
2 Oct 23
Cost Associated with Exit or Disposal Activities
8:49am
8-K
5xg87dplh9uina7
21 Jul 23
Termination of a Material Definitive Agreement
4:36pm
8-K
EX-99.1
1qrp3dif5r
25 May 23
Regulation FD Disclosure
5:10pm
8-K
EX-99.1
74swac vk26x25fnt
12 Dec 22
Regulation FD Disclosure
7:48am
8-K
EX-99.1
inn7zsmzw64l
16 Sep 22
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
4:15pm
8-K
86ome
16 Sep 22
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
4:15pm
425
atws80
15 Sep 22
Business combination disclosure
4:08pm
8-K
EX-99.1
r30d0 me8
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
8-K
rmjvam5s
15 Sep 22
Departure of Directors or Certain Officers
4:06pm